Trial Profile
Prophylactic therapy for cytomegalovirus in liver transplant recipients: a single center experience with oral ganciclovir versus valganciclovir
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalic inclusion disorders
- Focus Therapeutic Use
- 06 Nov 2006 New trial record.